Clinical Trial Update: A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pixantrone against doxorubicin in patients with diffuse large B-cell lymphoma has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Pixantrone (pixantrone)

Snippet

Sponsor: CTI BioPharma | Conditions: Diffuse Large-Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2024-05-30